Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

165.98
+1.490.91%
Post-market: 166.110.1300+0.08%19:53 EDT
Volume:3.18M
Turnover:527.99M
Market Cap:257.43B
PE:24.85
High:167.25
Open:164.04
Low:163.96
Close:164.49
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.84
T/O Rate:0.21%
Dividend:3.23
Dividend Rate:1.95%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.12
PE(LYR):25.38

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Aug 03

Pre-Market: Nasdaq Futures Gain 0.32% as US and Japan Jointly Intervene in Currency Markets

Deep News
·
Aug 03

U.S. Stocks on the MOVE-Atkore, Integer, Airlines

Reuters
·
Aug 03

US Stocks-Wall St Futures Gain on Mideast Deal Hopes; Healthcare in Focus

Reuters
·
Aug 03

Citi views report of AstraZeneca, Bristol Myers talks as surprising

TIPRANKS
·
Aug 03

AstraZeneca Investors Might Question Pipeline After Reports of Merger Talks

Dow Jones
·
Aug 03

Stocks to Watch: Bristol Myers Squibb, Alibaba, Palantir

Dow Jones
·
Aug 03

Premarket Movers | Alibaba up 4%; Atkore jumps 25%; BMY up 6%; AZN down 6%; PLTR up 2%

Tiger Newspress
·
Aug 03

Movement Alert|AstraZeneca PLC Falls 6.12% in Pre-Market Trading, Reportedly in Merger Talks With Bristol-Myers Squibb in Potential Record Pharma Deal

Market Focus
·
Aug 03

AstraZeneca Could Want to Move Closer to U.S. Market

Dow Jones
·
Aug 03

Movement Alert|AstraZeneca PLC Declines 3.68% Overnight, Reportedly in Merger Talks with Bristol-Myers Squibb in Potential $400 Billion Mega-Deal

Market Focus
·
Aug 03

AstraZeneca Can Hit Revenue Target on Its Own

Dow Jones
·
Aug 03

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval

MT Newswires Live
·
Jul 31

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Xencor Shares Rise After Settlement Deal With Alexion

MT Newswires Live
·
Jul 31

AstraZeneca’s DURGA-6 Trial Puts Cell Therapy in Direct Competition With Myeloma Transplants

TIPRANKS
·
Jul 31

AstraZeneca Slides Thursday, Underperforms Market

Dow Jones
·
Jul 31